Ensemble Health, a major player in healthcare revenue management, is seeking a potential $13 billion sale or IPO next year, Business Insider has learned. Ensemble, owned primarily by private equity firms Warburg Pincus and Berkshire Partners, has tapped JPMorgan to pursue a sale, five people with knowledge of the deal told Business Insider. At the same time, Ensemble is considering an IPO and has pulled in Goldman Sachs to support the dual-track approach, three of the people said. It’s aiming for a valuation of around $13 billion in either deal, according to those people.
Read the full article: Healthcare Company Ensemble Health Has Tapped JPMorgan as It Eyes a $13B Sale or IPO in 2026 //
Source: https://www.businessinsider.com/ensemble-health-hires-jpmorgan-goldman-sachs-for-sale-ipo-2025-10